違禁品定性篩檢試紙-Drug abuse

廣州健侖生物科技有限公司

廣州健侖生物科技有限公司是集研制開(kāi)發(fā)、銷(xiāo)售、服務(wù)于一體的優(yōu)良企業(yè),公司產(chǎn)品涉及臨床快速診斷試劑、食品安全檢測(cè)試劑，違禁品快速檢測(cè)，動(dòng)物疾病防疫檢測(cè)試劑，免疫診斷試劑、臨床血液學(xué)和體液學(xué)檢驗(yàn)試劑、微生物檢驗(yàn)試劑、分子生物學(xué)檢驗(yàn)試劑、臨床生化試劑、有機(jī)試劑等眾多領(lǐng)域，同時(shí)核心代理Panbio、FOCUS、Qiagen、IBL、CORTEZ、Fuller、Inbios、BinaxNOW、LumuQuick、日本富士、日本生研等多家有名診斷產(chǎn)品集團(tuán)公司產(chǎn)品，致力于為商檢單位、疾病預(yù)防控制中心、海關(guān)出入境檢疫局、衛(wèi)生防疫單位,緝毒系統(tǒng)，戒毒中心，檢驗(yàn)檢疫單位、生化企業(yè)、科研院所、醫(yī)療機(jī)構(gòu)等機(jī)構(gòu)與行業(yè)提供*、高品質(zhì)的產(chǎn)品服務(wù)。此外，本公司還開(kāi)展食品、衛(wèi)生、環(huán)境、藥品等多方面的第三方檢測(cè)服務(wù)。

廣州健侖生物長(zhǎng)期供應(yīng)各種違禁品檢測(cè)試紙、違禁品檢測(cè)卡、違禁品檢測(cè)試劑盒、藥篩試紙、藥篩試劑盒、嗎啡檢測(cè)試劑盒、巴比妥檢測(cè)試劑盒等。

使用說(shuō)明書(shū)

【產(chǎn)品名稱(chēng)】

通用名稱(chēng)：違禁品定性篩檢試紙-Drug abuse

英文名稱(chēng)：Diagnostic Kit for Nicotine（Colloidal Gold）

【包裝規(guī)格】 

1人份/袋、40人份/盒

Multi DOA Screen Panel are rapid chromatographic immunoassays for the qualitative and simultaneous detection of one to fourteen of the following drugs in a variety of combinations in human urine. The designed cutoff concentrations and direct calibrator for these drugs are as follows:

The test is used to obtain visual qualitative result and is intended for health care professionals use including professionals at point of care sites to assist in the determination of drug compliance. It is not intended for over the counter sale to non-professionals.

This assay provided only a preliminary analytical test result. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography/ Mass Spectrometry (GC/MS) or Liquid Chromatography/ Mass Spectrometry (LC/MS) are the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.

本品采用競(jìng)爭(zhēng)抑制法和膠體金免疫層析技術(shù)，用于定性檢測(cè)人體尿液中尼古丁，適用于尼古丁藥物濫用的初步篩查。

主營(yíng)品牌：美國(guó)NovaBios、美國(guó)Cortez、國(guó)產(chǎn)創(chuàng)侖等等。

主要用途：篩查違禁品濫用殘留、麻醉藥殘留、興奮藥物殘留等等。

檢測(cè)范圍：嗎啡、KET、mamp、MDMA、BZO、THC、巴比妥、MTD、BAR、MDMA、AMP、BUP、PCP、TCA、OXY、MET等等。

產(chǎn)品特點(diǎn)：可以根據(jù)需求自主訂制多聯(lián)卡。多聯(lián)卡自由組合，從二聯(lián)到十五聯(lián)都可以訂制。

我司還提供其它進(jìn)口或國(guó)產(chǎn)試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲(chóng)病、違禁品濫用、肺炎球菌、軍團(tuán)菌、化妝品檢測(cè)、食品安全檢測(cè)等試劑盒以及日本生研細(xì)菌分型診斷血清、德國(guó)SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

如需訂購(gòu)或者了解請(qǐng)以下或

mob： 楊   ： 

美國(guó)NOVABIOS多聯(lián)檢測(cè)杯簡(jiǎn)介：

美國(guó)NOVABIOS單卡產(chǎn)品簡(jiǎn)介：

w the test device, urine specimen, and/or controls to reach room temperature (15-30oC) prior to t

更多產(chǎn)品說(shuō)明可通過(guò)下方的進(jìn)行了解

添加掃一掃二維碼：

【公司名稱(chēng)】 廣州健侖生物科技有限公司

【 市場(chǎng)部 】       楊永漢
【】 
【騰訊  】
【公司地址】 廣州市清華科技園健新基地番禺石樓鎮(zhèn)健啟路63號(hào)二期2幢101-103室

內(nèi)質(zhì)網(wǎng)為由  生物膜構(gòu)成 的互相通連的片層隙狀或小管狀系統(tǒng)，膜片間的隙狀  空間稱(chēng)為池 ，通常與細(xì)胞外隙和細(xì)胞漿基質(zhì)之間不直接相通。這  種細(xì)胞內(nèi)的 膜性管道系統(tǒng)一方面構(gòu)成細(xì)胞內(nèi)物質(zhì)運(yùn)輸?shù)耐?，? 方面為細(xì)胞 內(nèi)各種各樣的酶反應(yīng)提供廣闊的反應(yīng)面積。內(nèi)質(zhì)網(wǎng)與  高爾基體及 核膜相連續(xù)。在病理狀態(tài)下，粗面內(nèi)質(zhì)網(wǎng)可發(fā)生量和  形態(tài)的改變 。在蛋白質(zhì)合成及分泌活性高的細(xì)胞（如漿細(xì)胞、胰  腺腺泡細(xì)胞 、肝細(xì)胞等）以及細(xì)胞再生和病毒感染時(shí)，粗面內(nèi)質(zhì)  網(wǎng)增多。粗 面內(nèi)質(zhì)網(wǎng)的含量高低也常反映腫瘤細(xì)胞的分化程度。  相反，在萎 縮的細(xì)胞（如饑餓時(shí)）以及有某種物質(zhì)貯積的細(xì)胞，  其粗面內(nèi)質(zhì) 網(wǎng)則萎縮、減少。當(dāng)細(xì)胞受損時(shí)，粗面內(nèi)質(zhì)網(wǎng)上的核  蛋白體往往 脫落于胞漿內(nèi)，粗面內(nèi)質(zhì)網(wǎng)的蛋白合成會(huì)下降或消失  ；當(dāng)損傷恢 復(fù)時(shí)，其蛋白合成也隨之恢復(fù)。在由各種原因引起的  細(xì)胞變性和 壞死過(guò)程中，粗面內(nèi)質(zhì)網(wǎng)的池一般出現(xiàn)擴(kuò)張，較輕的  和局限性的 擴(kuò)張只有在電鏡下才能窺見(jiàn)，重度擴(kuò)張時(shí)則在光學(xué)顯  微鏡下可表 現(xiàn)為空泡形成，電鏡下有時(shí)可見(jiàn)其中含有中等電子密  度的絮狀物 。
The endoplasmic reticulum is an interconnected lamellar or small tubular system composed of biofilms. The gap-like space between the membranes is called a pool and is usually not directly connected to the extracellular space and the cytoplasmic matrix. This type of intramembranous membranous tubing on the one hand constitutes a pathway for intracellular transport of substances, and on the other provides a wide reaction area for various enzymatic reactions within the cell. The endoplasmic reticulum is continuous with the Golgi apparatus and the nuclear membrane. In the pathological state, rough endoplasmic reticulum can occur in the amount and shape changes. The rough endoplasmic reticulum is increased in cells with high protein synthesis and secretion activity (such as plasma cells, pancreatic acinar cells, hepatocytes, etc.) and cell regeneration and virus infection. The content of rough endoplasmic reticulum also often reflects the degree of differentiation of tumor cells. Conversely, in atrophic cells (such as when starved) and cells that have a certain material storage, the rough endoplasmic reticulum shrinks and decreases. When the cells are damaged, the ribosomes on the rough endoplasmic reticulum often fall out of the cytoplasm, and the protein synthesis of the rough endoplasmic reticulum decreases or disappears; when the damage recovers, the protein synthesis also recovers. In the process of cell degeneration and necrosis caused by various reasons, the pool of rough endoplasmic reticulum generally expands, lighter and localized expansion can only be seen under electron microscopy, and can be seen under light microscope when severely expanded. For the formation of vacuoles, electron microscopy sometimes shows flocs with a medium electron density.